Citations

Mayo Clinic

Clear

612 citation(s) found for "Graff‐Radford, Jonathan".

Visuospatial impairment in logopenic progressive aphasia: Why do we not “see” it?
Pudumjee, Shehroo B. , Martin, Peter R. , Bailey, Kimberly, Caves, Courtney, Sharp, Blair, Graff‐Radford, Jonathan , Josephs, Keith A. , Whitwell, Jennifer L. , Duffy, Joseph R. , Clark, Heather M. , Botha, Hugo , Machulda, Mary M.

Alzheimer's & Dementia | December 31, 2021 | Volume: 17 | Issue: S6 | Pages: No page available

10.1002/alz.055810 Get It

AbstractBackgroundLogopenic progressive aphasia (LPA) and posterior cortical atrophy (PCA) have distinct patterns of hypometabolism and atrophy. However, these clinical syndromes overlap: visuospatial impairment has been documented in LPA and aphasia in PCA. Rey‐Osterrieth Complex Figure – Copy (Rey‐O Copy) performance is correlated with parietal‐occipital atrophy in LPA. We explore visuospatial impairment on the Rey‐O Copy in LPA and PCA with the Mayo Older Americans Normative Studies (MOANS; which uses Meyers & Meyers criteria) and the Boston Qualitative Scoring System (BQSS). We also examine the proportion of visuospatial impairment in LPA, an under‐appreciated phenomenon, compared to PCA wherein it is fundamental.MethodPatients with LPA (n=25) or PCA (n=23) were recruited by the Neurodegenerative Research Group. Patients underwent comprehensive neuropsychological testing (including Rey‐O Copy) at baseline visit. Cut‐offs of T‐score=40 (BQSS) or scaled score=7 (MOANS) were used based on normative data. Proportions of patients with low performance were examined across LPA and PCA groups. Individual logistic regressions and AUROC analyses were then conducted to quantify differences in visuospatial impairment in LPA and PCA with both scoring systems. Identical analyses were conducted using raw scores corrected for age and sex, to avoid confounds of adjustments in normative data.ResultLPA and PCA groups were comparable on age, sex, and disease duration (LPA Median = 2.7 years, IQR=1.9‐3.5; PCA Median = 3.6 years, IQR=1.5‐4.9); p=.823). Surprisingly, 52‐72% of LPA participants demonstrated impaired performance across scoring systems, relative to 96% of the PCA group identified by both scoring systems. Odds ratios (OR) for the Rey‐O Copy MOANS (OR = 1.59; p=.008) and BQSS Copy Presence and Accuracy index (CPA; OR = 1.13, p=.002) were significant, persisting for age‐ and sex‐ controlled raw scores, suggesting the odds of a PCA diagnosis increased with decrement on Rey‐O Copy. AUROC values ranged from 0.77 to 0.88 across these indices.ConclusionA substantial number of LPA participants showed visuospatial impairment, despite initial primary language complaints. Differentiation of diagnostic groups by the Rey‐O is likely underscored by relatively uniform, profound, visuospatial impairment in PCA with more variability in LPA. However, the degree of visuospatial impairment overlaps remarkably across diagnoses.
Successful cognitive aging definitions and associated demographic, biomarker profiles and lifestyles in the 80+ MCSA population
Arenaza‐Urquijo, Eider M. , Przybelski, Scott A. , Lesnick, Timothy G. , Pillai, Sheela Kumari Raghavan, Radford, Jonathan Graff, Petersen, Ronald C. , Arenaza-Urquijo, Eider M , Castillo, Anna , Mielke, Michelle M. , Machulda, Mary M. , Knopman, David S. , Jack, Clifford R. , Vemuri, Prashanthi

Alzheimer's & Dementia | December 31, 2021 | Volume: 17 | Issue: S6 | Pages: No page available

10.1002/alz.055700 Get It

AbstractBackgroundThere have been no standard definitions of successful cognitive aging (SA). Our goal was to apply different SA definitions to the 80+ population in the Mayo Clinic Study of Aging (MCSA) on the basis of (i) cross‐sectional vs longitudinal cognition (“Exceptionality” vs “Maintenance”) and (ii) memory vs global cognitive scores and explore the participant characteristics for each SA definition on the basis of baseline imaging markers and mid/late‐life health.MethodWe included 2157 participants from the MCSA, all ≥80 years at baseline and classified them into two SA definitions using memory z‐scores or global z‐scores: “Exceptionality” when high cognitive performance was observed (z‐scores ≥ 1 SD), “Maintenance” when cognitive function was preserved over time (Slope ≥ ‐0.1/year using mixed‐effect models). Our imaging markers were: PET‐based amyloid positivity (A+), MRI‐based neurodegeneration positivity (N+), WMH, FDG‐PET SUVR markers of resilience (anterior cingulate, ACC) and AD‐related areas (posterior cingulate). We also examined APOE4 status and other health characteristics. Group comparison was performed within each definition (e.g. exceptional vs non‐exceptional memory) using ANCOVA and binary logistic regressions with adjustments for age, sex, and education.ResultA lower number of participants met the “Exceptionality” criteria (10%: memory and 4%: global). A greater number met the “Maintenance” criteria (53%: memory and 32%: global). Less than 7% showed both “Exceptional” cognition and “Maintenance” over time. Participants across SA definitions were in general younger, more often women, with a higher education/occupation and less often APOE4 carriers. All SA groups showed higher ACC metabolism and lower N+ compared to the corresponding non‐SA group. More than 50% of the participants in the “Exceptional” groups were A+ (57%: memory, 50%: global). A+ frequency was significantly lower in the “Maintainers” (<42%). Better mid/late‐life health indicators were observed in the SA groups, including lower cardio‐metabolic conditions, higher mid‐life cognitive activities, lower depressive symptomatology, lower hypersomnolence and better self‐perception of health.ConclusionDifferent SA definitions identified mainly non‐overlapping 80+ groups that showed several common features including higher education/occupation, percent of women, better lifestyles, lower N+ frequency, and higher ACC metabolism. Lower A+ frequency was a key distinct feature of “Maintenance”.
Effects of protocol and scanner changes on segmentation volume estimates in a dedicated crossover data set
Gunter, Jeffrey L. , Wiste, Heather J. , Weigand, Stephen D. , Graff‐Radford, Jonathan , Petersen, Ronald C. , Kantarci, Kejal , Vemuri, Prashanthi , Schwarz, Christopher G. , Mielke, Michelle M. , Knopman, David S. , Jack, Clifford R.

Alzheimer's & Dementia | December 31, 2021 | Volume: 17 | Issue: S1 | Pages: No page available

10.1002/alz.056459 Get It

AbstractBackgroundThe Mayo Clinic Study of Aging and Alzheimer’s Disease Research Center used GE scanners exclusively for MRI from 2005‐2017, employing consistent imaging parameters throughout. In 2017 the MRI protocol was updated and migrated to Siemens Prisma scanners; 113 participants were scanned with each configuration. The GE protocol included a 2D FLAIR. The Siemens protocol includes 3D FLAIR and T2‐weighted images. Both vendor protocols included a 3D T1. Experience with multi‐center trials suggests such changes may introduce systematic variations.MethodsGE scanning was carried out on 3T scanners with 12 channel phased array head coils. Siemens Prisma scanning was carried out with 64 channel head/neck coils. Imaging sequences and parameters are given in Table 1. We used the MCALT template and priors to perform standard six‐class segmentation on T1‐weighted (T1w) images. SPM12 unified segmentation supports the simultaneous use of multiple input contrasts; segmentation of multi‐contrast inputs was done using eight tissue classes including deep grey and white matter hyperintensity (WMH) priors. For a given MRI study (either GE or Siemens) all images were registered and resampled to the study’s T1w image. Two‐channel (T1+FLAIR) segmentation was performed on GE scans. Two and three‐channel segmentations were performed on Siemens scans. Comparisons included total intracranial volume, total tissue volume and total grey matter volumes, as well as hippocampal volumes and grey matter volume in a temporal lobe meta‐ROI.ResultsFour participants were excluded for poor image quality: one poor GE T1w quality, one poor Siemens T1, T2 and FLAIR quality, and two poor Siemens T2 quality. Comparisons were made among 109 participants aged 34–97 (Table 2). By visual assessment, adding T2‐weighted images always improved intracranial volume correctness. Using the combination of single‐channel GE and three‐channel Siemens generally improved cross‐vendor agreement on grey matter volumes with the exceptions of hippocampal and intracranial volume estimates.ConclusionRequiring multiple input channels increases the likelihood that the result of a study being excluded. Combining T1w, FLAIR and T2w images allows the delineation of WMH and deep grey matter probability outputs but may introduce differences in GM volumes.
Diffusion tensor imaging findings in empirically derived incident MCI subtypes
Mester, Carly , Albertson, Sabrina M., Pillai, Sheela Kumari Raghavan, Graff‐Radford, Jonathan , Petersen, Ronald C. , Bondi, Mark W. , Machulda, Mary M. , Lundt, Emily S. , Reid, Robert I. , Schwarz, Christopher G. , Jack, Clifford R. , Knopman, David S. , Mielke, Michelle M. , Kremers, Walter K. , Jones, David T. , Vemuri, Prashanthi

Alzheimer's & Dementia | December 31, 2021 | Volume: 17 | Issue: S1 | Pages: No page available

10.1002/alz.054998 Get It

AbstractBackgroundEarly changes in white matter (WM) measured using diffusion tensor imaging (DTI) are sensitive markers of WM degeneration and predict future cognitive decline in mild cognitive impairment (MCI). We sought to examine whether changes in WM integrity differed among empirically derived subtypes of incident MCI.MethodParticipants included 66 individuals with incident MCI enrolled in the population‐based Mayo Clinic Study of Aging (MCSA) previously identified via cluster analysis as having one of four MCI subtypes: subtle cognitive impairment (SCI; n = 13, mean age 78; 15% women), amnestic (n = 24; mean age 79; 54% women), dysnomic (n = 8; mean age 79; 38% women), and dysexecutive (n = 21; mean age 82; 33% women). All participants completed 3T MRI at the time of the MCI diagnosis. We compared the MCI subtypes to 100 cognitively unimpaired (CU) participants (mean age 77; 49% women). We used tract‐based spatial statistics to examine voxel‐level differences in fractional anisotropy (FA). We also fit a linear regression model to regional FA data from the corpus callosum (CC), the major interhemispheric WM connection, to quantify the relative differences in WM damage.ResultAll MCI subtypes except the subtle cognitive impairment group had widespread decreased FA. Relative to CU, the amnestic cluster showed decreased FA in the CC (genu), cingulum, fornix and uncinate fasciculus (UF); the dysnomic cluster showed decreased FA in the CC (genu, splenium), fornix, UF, anterior thalamic radiation (ATR), and corticospinal tract (CST); and the dysexecutive group showed decreased FA in the CC (genu, body, splenium), cingulum, UF, ATR, CST, and superior longitudinal fasciculus. The dysexecutive cluster had the most severe bilateral involvement among all MCI subtypes. The regional analysis showed that the amnestic, dysnomic, and dysexecutive groups (but not the subtle cognitive impairment group) had significantly lower FA of the CC compared to CU (p<0.001; Figure 1).ConclusionWe found widespread WM degeneration in the commissural and long association fibers in amnestic, dysnomic, and dysexecutive incident MCI subtypes. The extent of CC damage seen in Figure 1. confirmed the voxel‐level results and suggests that interhemispheric WM disconnection is relevant to the development of MCI.
Time in therapeutic range of anticoagulation among patients with atrial fibrillation and cerebral amyloid angiopathy
Graff‐Radford, Jonathan , Ponamgi, Shiva , English, Stephen , Meskill, Alayna, Challa, Apurva B., Hodge, David O. , Slusser, Joshua P. , Asirvatham, Samuel J. , Holmes, David R. , Ward, Robert C. , Asirvatham, Samuel J , Rabinstein, Alejandro A. , DeSimone, Christopher V.

Baylor University Medical Center Proceedings | December 28, 2021 | Volume: 35 | Issue: 2 | Pages: 162-167

10.1080/08998280.2021.2013393 | PMID 35261442 Get It

The temporal onset of the core features in dementia with Lewy bodies
Choudhury, Parichita , Graff‐Radford, Jonathan , Aakre, Jeremiah A. , Wurtz, Lincoln , Graff‐Radford, Neill R. , Kantarci, Kejal , Forsberg, Leah K. , Fields, Julie A. , Pedraza, Otto , Chen, Qin , Miyagawa, Toji , Day, Gregory S. , Tipton, Philip W. , Savica, Rodolfo , Lachner, Christian , Dredla, Brynn K., Reichard, R. Ross , Petersen, Ronald C. , Ferman, Tanis J. , Tipton, Philip, Dredla, Brynn, Tipton, Philip W , Kantarci, Kejal , Day, Gregory S , Ferman, Tanis J , Choudhury, Parichita , Knopman, David S. , Botha, Hugo , Dickson, Dennis W. , Boeve, Bradley F.

Alzheimer's & Dementia | November 11, 2021 | Volume: 18 | Issue: 4 | Pages: 591-601

10.1002/alz.12411 | PMID 34761850 Get It

AbstractIntroductionWe examined the temporal sequence of the core features in probable dementia with Lewy bodies (DLB).MethodsIn 488 patients with probable DLB, the onset of each core feature and time to diagnosis was determined for men and women, and a pathologic subgroup (n = 209).ResultsREM sleep behavior disorder (RBD) developed before the other core features in men and women. Men were more likely to have RBD and were diagnosed with probable DLB earlier than women. Visual hallucinations developed after the other core features in men, but in women, they appeared earlier and concurrently with fluctuations and parkinsonism. Women were older and more cognitively impaired at first visit, were less likely to have RBD, more likely to be diagnosed with probable DLB later than men, and more likely to have neocortical tangles.DiscussionAn earlier latency to probable DLB was associated with men, RBD, and Lewy body disease without neocortical tangles.
Associations of amyloid and neurodegeneration plasma biomarkers with comorbidities
Syrjanen, Jeremy A. , Campbell, Michelle R. , Algeciras‐Schimnich, Alicia , Vemuri, Prashanthi , Graff‐Radford, Jonathan, Bu, Guojun , Jack, Clifford R. , Petersen, Ronald C. , Algeciras-Schimnich, Alicia , Jack, Clifford R , Vemuri, Prashanthi , Bu, Guojun , Graff‐Radford, Jonathan , Machulda, Mary M. , Knopman, David S. , Mielke, Michelle M.

Alzheimer's & Dementia | September 27, 2021 | Volume: 18 | Issue: 6 | Pages: 1128-1140

10.1002/alz.12466 | PMID 34569696 Get It

AbstractIntroductionBlood‐based biomarkers of amyloid pathology and neurodegeneration are entering clinical use. It is critical to understand what factors affect the levels of these markers.MethodsPlasma markers (Aβ42, Aβ40, NfL, T‐tau, Aβ42/40 ratio) were measured on the Quanterix Simoa HD‐1 analyzer for 996 Mayo Clinic Study of Aging (MCSA) participants, aged 51 to 95 years. All other data were collected during in‐person MCSA visits or abstracted from the medical record.ResultsAmong cognitively unimpaired (CU) participants, all plasma markers correlated with age. Linear regression models revealed multiple relationships. For example, higher Charlson Comorbidity Index and chronic kidney disease were associated with higher levels of all biomarkers. Some relationships differed between mild cognitive impairment and dementia participants.DiscussionMultiple variables affect plasma biomarkers of amyloid pathology and neurodegeneration among CU in the general population. Incorporating this information is critical for accurate interpretation of the biomarker levels and for the development of reference ranges.
Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease
Buciuc, Marina , Josephs, Keith A. , Jones, David T. , Whitwell, Jennifer L. , Graff‐Radford, Jonathan , Josephs, Keith A , Buciuc, Marina , Jones, David T , Whitwell, Jennifer L , Graff-Radford, Jonathan

Neurology | September 10, 2021 | Volume: 97 | Issue: 19 | Pages: 908-909

10.1212/wnl.0000000000012783 | PMID 34504027 Get It

Deep learning-based brain age prediction in normal aging and dementia
Lee, Jeyeon , Burkett, Brian J. , Senjem, Matthew L. , Lundt, Emily S. , Botha, Hugo, Graff‐Radford, Jonathan , Barnard, Leland R , Gunter, Jeffrey L. , Schwarz, Christopher G. , Lowe, Val J. , Petersen, Ronald C. , Jones, David, Schwarz, Christopher G , Senjem, Matthew L , Burkett, Brian , Min, Hoon-Ki Paul , Kantarci, Kejal , Knopman, David S. , Boeve, Bradley F. , Jack, Clifford R. , Jones, David, Lundt, Emily S

No container title available | August 24, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-804454/v1 Get It

Abstract Normal brain aging is accompanied by patterns of functional and structural change. Alzheimer's disease (AD), a representative neurodegenerative disease, has been linked to accelerated brain aging at respective age ranges. Here, we developed a deep learning-based brain age prediction model using fluorodeoxyglucose (FDG) PET and structural MRI and tested how the brain age gap relates to degenerative cognitive syndromes including mild cognitive impairment, AD, frontotemporal dementia, and Lewy body dementia. Occlusion analysis, performed to facilitate interpretation of the model, revealed that the model learns an age- and modality-specific pattern of brain aging. The elevated brain age gap in dementia cohorts was highly correlated with the cognitive impairment and AD biomarker. However, regions generating brain age gaps were different for each diagnosis group of which the AD continuum showed similar patterns to normal aging in the CU.